Variant report
Variant | esv3444288 |
---|---|
Chromosome Location | chr1:153195950-153202182 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:258)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:152842274..152842902-chr1:153195531..153196166,2 | K562 | blood: | |
2 | chr1:153199630..153201590-chr1:153203722..153207210,3 | K562 | blood: | |
3 | chr1:152842126..152842930-chr1:153201547..153202193,2 | K562 | blood: | |
4 | chr1:152841961..152842705-chr1:153201839..153202398,2 | MCF-7 | breast: | |
5 | chr1:152890154..152890898-chr1:153195415..153196086,2 | K562 | blood: | |
6 | chr1:153162642..153163332-chr1:153195160..153195963,2 | MCF-7 | breast: | |
7 | chr1:153188340..153191053-chr1:153194176..153196753,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000230779 | TF binding region |
ENSG00000203783 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560060749 | chr1:153195970-153195971 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs66775546 | chr1:153196019-153196020 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs3058228 | chr1:153196022-153196023 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs369138840 | chr1:153196077-153196078 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs537938162 | chr1:153196079-153196080 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs549170083 | chr1:153196112-153196113 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs35713450 | chr1:153196223-153196224 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs531455074 | chr1:153196231-153196232 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs551528168 | chr1:153196233-153196234 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs571347792 | chr1:153196255-153196256 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs533813974 | chr1:153196261-153196262 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs547414864 | chr1:153196269-153196270 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs567177670 | chr1:153196274-153196275 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs535736508 | chr1:153196275-153196276 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs143281129 | chr1:153196301-153196302 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs575721219 | chr1:153196305-153196306 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs77035569 | chr1:153196320-153196321 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs73010321 | chr1:153196325-153196326 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs577711172 | chr1:153196341-153196342 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs78601493 | chr1:153196381-153196382 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs374788610 | chr1:153196437-153196438 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs146685745 | chr1:153196488-153196489 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs573895139 | chr1:153196498-153196499 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs542525786 | chr1:153196541-153196542 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs562778897 | chr1:153196577-153196578 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs140247766 | chr1:153196586-153196587 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs535420421 | chr1:153196590-153196591 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs80006771 | chr1:153196656-153196657 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs61801955 | chr1:153196659-153196660 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs565021010 | chr1:153196669-153196670 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs572277437 | chr1:153196685-153196686 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs118039842 | chr1:153196696-153196697 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs150292018 | chr1:153196702-153196703 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs565987062 | chr1:153196725-153196726 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs533876653 | chr1:153196730-153196731 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs569519120 | chr1:153196774-153196775 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs112877463 | chr1:153196784-153196785 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs564291767 | chr1:153196809-153196810 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs373543764 | chr1:153196812-153196813 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs192546216 | chr1:153196875-153196876 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs34005908 | chr1:153196879-153196880 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs184982317 | chr1:153196906-153196907 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs145426207 | chr1:153196908-153196909 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs188744346 | chr1:153196943-153196944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs573976554 | chr1:153196962-153196963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542991442 | chr1:153196976-153196977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs114274433 | chr1:153197000-153197001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576285712 | chr1:153197005-153197006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144626547 | chr1:153197051-153197052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs545228865 | chr1:153197083-153197084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 21129771 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Osteosarcoma | 17242211 | CNVD |
Ovarian cancer | 17242211 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Schizophrenia | 18990708 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Plasma-cell dyscrasia | 16705089 | CNVD |
Myeloma | 17024118 | CNVD |
Cancer | 17060936 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Gastrointestinal cancer | 16790693 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21611746 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:153183200-153205000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr1:153192800-153196600 | Enhancers | Ovary | ovary |
3 | chr1:153196200-153196400 | Bivalent Enhancer | Hela-S3 | cervix |
4 | chr1:153196200-153196600 | Enhancers | GM12878-XiMat | blood |
5 | chr1:153197800-153198000 | Flanking Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr1:153198000-153198200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr1:153201600-153201800 | Enhancers | Lung | lung |
8 | chr1:153201800-153203600 | Weak transcription | Lung | lung |
9 | chr1:153201800-153204400 | Enhancers | Primary neutrophils fromperipheralblood | blood |